Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1983-01-24
1985-02-12
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 4502, A61K 3185, A61K 3115
Patent
active
044990723
ABSTRACT:
This invention relates to the improvement of the polyamine depletion effects of ornithine decarboxylase inhibitors and/or S-adenosylmethionine decarboxylase inhibitors, the improvement being effected by the use of interferon in conjunctive therapy with said inhibitors.
REFERENCES:
Chemical Abstracts, vol. 87, p. 27, Abstract No. 177545d, 1977.
Chemical Abstracts, vol. 97, p. 26, Abstract No. 192818v, 1982.
Chemical Abstracts, vol. 97, p. 203, Abstract No. 194368x, 1982.
Chemical Abstracts, vol. 93, p. 537, Abstract No. 47975a.
Sikora, K., British Medical Journal, vol. 281, pp. 855-858, 1980.
Prakash Nellikunja J.
Sunkara Sai P.
Hazel Blondel
McDonald Raymond A.
Merrell Dow Pharmaceuticals Inc.
Nesbitt Stephen L.
Street Gary D.
LandOfFree
Process for treating diseases with ODC inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for treating diseases with ODC inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treating diseases with ODC inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1389021